Form 4: Thermo Fisher Officer Reports Stock Transactions

Joseph R. Holmes, VP & Chief Accounting Officer at Thermo Fisher Scientific, reported multiple stock transactions including option exercises and sales.

Summary

• Joseph R. Holmes, VP & Chief Accounting Officer of Thermo Fisher Scientific Inc. (TMO), reported several transactions involving the company's common stock.
• On August 28, 2025, Holmes disposed of a total of 36.984 shares of common stock at a price of $489.74 per share. These 'F' transactions typically represent shares withheld for tax obligations related to equity awards.
• On August 29, 2025, Holmes exercised stock options to acquire 385 shares of common stock at an exercise price of $253.99 per share.
• Immediately following the option exercise, on August 29, 2025, Holmes sold a total of 385 shares of common stock in two separate transactions at prices of $492.615 and $492.633 per share.
• Following all reported transactions, Holmes' direct beneficial ownership stands at 2,318.9815 shares of common stock.
• The filing also notes that 54.846 shares were acquired under the Issuer's employees' stock purchase plan on May 15, 2025.
• The exercised options vested in four equal installments on February 26, 2020, 2021, 2022, and 2023, and had an expiration date of February 26, 2026.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. While there's a sale of shares, it's directly tied to an option exercise, indicating the executive realized a gain on their compensation. This is a common and expected event for executives managing their equity, rather than a signal of lack of confidence in the company.

Positives

• The exercise of stock options indicates a realized gain for the insider, as the exercise price of $253.99 is significantly lower than the sale prices of approximately $492.60 per share.
• The transactions demonstrate the executive's participation in the company's equity compensation plans, aligning their interests with shareholders.

Negatives

• The sale of 385 shares by a key executive reduces their direct equity exposure to the company, although this is a common practice following option exercises to cover taxes or for personal financial planning.

Stakeholder Impact

• Shareholders: Provides transparency into executive stock ownership and transactions, which can influence investor sentiment regarding management's alignment with shareholder interests.

Key Dates

Recommendation

The reported transactions are routine for an executive exercising stock options and selling shares to cover taxes or diversify. They do not indicate a significant change in the company's fundamentals or a strong signal for future stock performance, thus a 'hold' recommendation is appropriate based solely on this filing.

Keywords

Thermo Fisher Scientific, TMO, Joseph R. Holmes, Insider Trading, Form 4, Stock Options, Share Sale, Executive Compensation, Beneficial Ownership